002437: HARBIN GLORIA PHARMACEUTICALS Co., LTD - Summary | Jitta

HARBIN GLORIA PHARMACEUTICALS Co., LTD

CHN:002437

Price
CN¥2.59
Loss Chance
44.2%
5.50JITTA SCORE
20.36%Over Jitta Line
Jitta Ranking
28 / 486
332 / 5,271
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (45)
Recent Business Performance (67)
Financial Strength (88)
Return to Shareholders (25)
Competitive Advantage (44)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing Every Year
Revenue and EarningRevenue decline from 2022-2025
Key Stats
Jitta Score
Jitta Line
5.50
20.36%
4.41
> 1,000%
4.23
> 1,000%
Pharmaceuticals
7.60
0.42%
5.63
26.59%
7.34
37.52%
COMPANY DESCRIPTION
HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China.